Novel fused imidazotriazines acting as promising top. II inhibitors and apoptotic inducers with greater selectivity against head and neck tumors: Design, synthesis, and biological assessments

Autor: Al-Karmalawy, Ahmed A., Rashed, Mahmoud, Sharaky, Marwa, Abulkhair, Hamada S., Hammouda, Mohamed M., Tawfik, Haytham O., Shaldam, Moataz A.
Zdroj: In European Journal of Medicinal Chemistry 5 November 2023 259
Databáze: ScienceDirect